Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.windlasbiotech.com | |
Market Cap | 1,152.45 Cr. | |
Enterprise Value(EV) | 1,127.26 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 25.31 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 21.89 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 207.35 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 2.67 | Calculated using Price: 554.10 |
Dividend Yield | 0.72 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.08 Cr. | 20,798,575 Shares |
FaceValue | 5 | |
About Windlas Biotech Ltd. | ||
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. |
1 Day |
|
-1.95% |
1 Week |
|
+3.74% |
1 Month |
|
+3.42% |
3 Month |
|
+13.97% |
6 Month |
|
+66.91% |
1 Year |
|
+118.89% |
2 Year |
|
+108.34% |
5 Year |
|
|
10 Year |
|
6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 9.17 | 40.43 | 8.04 | 7.62 | 12.87 | 10.76 | |
Return on Capital Employed (%) | 14.61 | 40.11 | 11.81 | 9.85 | 14.88 | 14.39 | |
Return on Assets (%) | 3.87 | 21.75 | 5.1 | 4.91 | 9.7 | 8.39 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 125 | 194 | 210 | 199 | 395 | 402 | 416 | |
Non Curr. Liab. | 21 | 8 | 3 | 4 | 0 | 3 | 3 | |
Curr. Liab. | 143 | 96 | 125 | 93 | 94 | 121 | 149 | |
Minority Int. | ||||||||
Equity & Liab. | 289 | 298 | 338 | 296 | 489 | 527 | 568 | |
Non Curr. Assets | 145 | 177 | 170 | 102 | 107 | 173 | 180 | |
Curr. Assets | 144 | 120 | 168 | 194 | 382 | 354 | 388 | |
Misc. Exp. not W/O | ||||||||
Total Assets | 289 | 298 | 338 | 296 | 489 | 527 | 568 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 352 | 307 | 329 | 428 | 466 | 513 | 600 | |
Other Income | 4 | 4 | 2 | 3 | 7 | 10 | 11 | |
Total Income | 356 | 312 | 331 | 431 | 473 | 523 | 612 | |
Total Expenditure | -313 | -269 | -287 | -373 | -414 | -453 | -528 | |
PBIDT | 44 | 43 | 44 | 58 | 59 | 70 | 84 | |
Interest | -6 | -5 | -3 | -1 | -1 | -1 | -1 | |
Depreciation | -17 | -11 | -9 | -13 | -12 | -12 | -13 | |
Taxation | -9 | -12 | -8 | -6 | -7 | -14 | -17 | |
Exceptional Items | 50 | -22 | ||||||
PAT | 11 | 64 | 16 | 16 | 38 | 43 | 53 | |
Minority Interest | 0 | |||||||
Share Associate | ||||||||
Other Related Items | ||||||||
Consolidated Net Profit | 11 | 64 | 16 | 16 | 38 | 43 | 53 | |
Adjusted EPS | 7 | 35 | 9 | 9 | 17 | 20 | 25 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 35 | 19 | 25 | 11 | 9 | 61 | |
Cash Fr. Inv. | -11 | -5 | -14 | -20 | -155 | -14 | |
Cash Fr. Finan. | -26 | -6 | -5 | 1 | 130 | -44 | |
Net Change | -2 | 7 | 5 | -8 | -15 | 3 | |
Cash & Cash Eqvt | 7 | 13 | 18 | 16 | 1 | 4 |
Wed, 24 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Windlas Biotech Limited has informed the Exchange about Schedule of meet |
Sun, 14 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Windlas Biotech Limited has informed the Exchange about Schedule of meet |
Tue, 09 Apr 2024
Trading Window-XBRL WINDLAS BIOTECH LIMITED has informed the Exchange about Closure of Trading Window |
Thu, 25 Apr 2024 |
Closing Below Previous Low |
Close Within 52 Week High Zone |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |